For the ARDG, these genes were significantly enriched in some cancer-related pathways (such as “pathways in cancer”, “prostate cancer” and “bladder cancer”) as well as pathways highly associated with cancer including the “p53 signaling pathway” and “PI3K-Akt signaling pathway” (Table S1). This evidence concerns the gene TP53 and prostate carcinoma.